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Abstract 26 
The occurrence of pharmaceutical and illicit drug residues potentially arising 27 
from combined sewer overflows (CSOs) in the Central London portion of the 28 
Thames Estuary is presented. Approximately 39 million tonnes of untreated 29 
sewage enter the River Thames at 57 CSO points annually. Differential analysis 30 
of influents and effluents in a major wastewater treatment plant identified seven 31 
potential drug-related CSO markers based on removal rates. Three were 32 
present in influent at concentrations >1 µg L-1 (caffeine, cocaine and 33 
benzoylecgonine). During dry weather, analysis of hourly samples of river water 34 
revealed relatively consistent concentrations for most drugs, including CSO 35 
markers, over a tidal cycle. River water was monitored over a week in January 36 
and July and then daily across six consecutive weeks in November/December 37 
2014. Out of 31 compounds monitored, 27 drug residues were determined in 38 
the River Thames and, combined, ranged between ~1,000-3,500 ng L-1. Total 39 
drug concentration generally declined during extended periods of drier weather. 40 
For CSO markers, short-term increases in caffeine, cocaine and 41 
benzoylecgonine concentration were observed ~24 h after CSO events 42 
(especially those occurring at low tide) and generally within one order of 43 
magnitude. Timings of elevated occurrence also correlated well with 44 
ammonium ion and dissolved oxygen data following CSOs. This work also 45 
represents an important study of pharmaceutical occurrence before a major 46 
‘Super Sewer’ infrastructure upgrade in London aiming to reduce CSOs by 47 
95 %.  48 
Keywords: river water monitoring, emerging contaminants, high resolution 49 
mass spectrometry, CSOs  50 
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1. Introduction 51 
Pharmaceuticals as environmental contaminants have been the focus of 52 
much research in the past 20 years. Concentrations, generally in the ng-µg L-1 53 
range, have now been reported in most environmental compartments including 54 
wastewater [1-3], surface/ground water [4-6], marine water [7-9], solids [10], 55 
biota [11] and even in air [12]. However, the primary source of pharmaceutical 56 
and illicit drug contamination in the receiving environment has been identified 57 
as outputs from wastewater treatment plants (WWTPs), as either treated 58 
effluent or via sludge. In the EU, some pharmaceutical compounds have been 59 
placed on a ‘watch-list’ until sufficient evidence on the full extent of their impacts 60 
is known [13]. Environmental contamination and effects of illicit drugs have also 61 
been reported, albeit on a smaller scale to pharmaceuticals, and the focus for 62 
these has been largely on their measurement in untreated wastewater to 63 
estimate community consumption patterns [14-16].  64 
As part of the wastewater infrastructure of many developed towns and 65 
cities, combined sewers are often used to simultaneously carry storm water and 66 
municipal sewage to urban WWTPs. Such sewers are often designed to carry 67 
several fold the average dry-weather load, but in extreme cases of runoff, 68 
rainfall or snowmelt, capacity can be breached. In these cases, combined 69 
sewer overflow (CSO) events occur to avoid back-flooding of streets and 70 
homes. Storm flow is normally mixed with treated or untreated wastewater and 71 
released directly into a nearby river or water body. Many reports have detailed 72 
the resultant changes in water quality [17] and ecosystem impacts [18] arising 73 
from faecal matter [19], microbial pathogens [20, 21], priority pollutants [22] and 74 
other storm water-related contents [23] .  75 
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In London, ~39 million tonnes of untreated sewage is discharged into the 76 
river Thames every year on average, but following exceptional wet weather and 77 
flooding in 2014, that total rose to 62 million tonnes [24]. London is mostly 78 
served by a Victorian combined sewer system built by Sir Joseph Bazalgette 79 
following the ‘Great Stink’ of 1858. From 1831 until its completion in 1865, an 80 
estimated 40,000 Londoners died from cholera. The expansion of London and 81 
an increasing population (>8.3 m) has meant that the system is currently 82 
running at approximately 80 % of its capacity, resulting in more frequent 83 
breaches with CSOs occurring at least once a week, even at times of light 84 
rainfall. London’s sewer system contains 57 CSO vents, 36 of which were 85 
assessed as having adverse environmental effects [25, 26]. CSO discharges 86 
were found to reduce the dissolved oxygen (DO) levels in river, introduce 87 
pathogenic organisms and to cause negative aesthetic changes in the river 88 
through the release of sewage, sewage litter, grease and scum directly into the 89 
river. A potential solution has been the Thames Tideway Tunnel, or ‘Super 90 
Sewer’, currently being built ~66 m under the river over 25 km. This major 91 
upgrade will intercept 34 CSOs and reroute sewage to a relief WWTP at 92 
Beckton in east London. It is due to be completed by 2023 and aims for an 93 
average 95 % reduction in sewage discharged to the river [27].  94 
In comparison to prioritised pollutants, the impact of CSOs containing 95 
multiple pharmaceutical residues on receiving waters has received relatively 96 
little attention. A recent study by Kay et al. [28], showed that concentrations of 97 
five compounds monitored over 18 months in non-tidal rivers did not decrease 98 
even 5 km from the nearest WWTP in Northern England, which may potentially 99 
influence risk assessments based on models using first-order decay kinetics in 100 
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rivers [29]. Repeated sampling was also performed to identify fluctuations 101 
across a day, which showed significant variance in measured concentrations 102 
and, in some cases, across two-three orders of magnitude. A second study by 103 
Benotti and Brownawell near New York City reported concentrations of 12 high-104 
volume pharmaceutical residues in mixed freshwater-saline regions across 105 
Jamaica Bay during dry and wet weather conditions [30]. Of these, two 106 
compounds had similar or higher concentrations in comparison to dry weather 107 
conditions (acetaminophen and nicotine). Despite being a comprehensive 108 
spatial study, repeated sampling was not performed to monitor temporal 109 
changes at each site. However, this study demonstrated the effect of salinity on 110 
pharmaceutical concentrations. Weyrauch et al. showed that compounds with 111 
removal efficiencies >95 % during wastewater treatment could result in 112 
elevated concentration in river water after CSOs [31]. For example, and though 113 
not a pharmaceutical, concentrations of nitrilotriacetic acid in the River Spree 114 
increased by 10-fold following a CSO and was well removed by a WWTP in 115 
Berlin. Compounds with intermediate removal above ~56 % also showed an 116 
increase in some cases, despite dilution with rainwater. Madoux-Humery et al., 117 
performed high resolution temporal sampling of sewage outfalls over a year in 118 
Canada [32]. Several CSO markers were monitored and E. coli was considered 119 
the best overall. However, of four pharmaceuticals monitored, carbamazepine 120 
was determined to be the best marker of CSOs due to its persistence, specificity 121 
for human use, stability and correlation with E. coli. Previous work by the same 122 
group showed that caffeine was correlated with faecal coliforms [33] and its use 123 
as an indicator of wastewater contamination was also shown by other groups 124 
in different parts of the world [34-38]. Acetaminophen was also identified as a 125 
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suitable CSO marker by other groups [38, 39]. In an alternative approach, Fono 126 
et al. showed that chirality could be exploited to identify raw sewage discharges 127 
and/or CSOs using the ratio of one of the isomers of propranolol to its total 128 
concentration [40]. Aside from CSOs, use of drug markers has also recently 129 
been proposed to differentiate sewage from manure contamination [41]. Save 130 
for a few studies [42-44], the number of pharmaceuticals and especially illicit 131 
drugs included is generally small. More comprehensive analytical methods are 132 
required to fully identify the scale of CSO impacts more broadly regarding such 133 
compounds. Ideally, these should be more tailored to the catchment at the 134 
method development stage. The advent of liquid chromatography-high 135 
resolution mass spectrometry (LC-HRMS) has enabled a more flexible 136 
approach to multi-residue analysis, by allowing targeted, untargeted and 137 
suspect screening to be performed on large numbers of compounds, often 138 
simultaneously [45-48]. However, reports using such approaches for CSO 139 
impact assessment on receiving waters for pharmaceuticals and illicit drugs are 140 
few. 141 
The aim of this work was to identify fluctuations in drug concentrations 142 
in the Central London catchment of the River Thames potentially arising from 143 
CSO events. The objectives were (a) to perform a differential quantitative 144 
analysis of influent and effluent wastewater to identify CSO-related drug 145 
markers, and (b) to monitor fluctuations in general drug occurrence, as well as 146 
ammonium and DO in receiving river water during dry and wet weather. In 147 
particular, sampling sites were chosen for their location ~25 km away from any 148 
main WWTP effluent discharge points. This project focused on quantitative 149 
monitoring of a larger number of pharmaceutical and illicit drug compounds than 150 
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studied previously (n=31), and measured at high frequency, with an analytical 151 
method based on LC-HRMS that was flexibly adapted for the catchment. Also, 152 
this work serves as a potential snapshot of drug contamination before a major 153 
sewer infrastructure upgrade such as the Thames ‘Super Sewer’ project. 154 
 155 
2. Experimental 156 
2.1  Materials and Reagents 157 
All reagents were of analytical grade or higher. Methanol (MeOH), acetonitrile 158 
(MeCN), dichloromethane (DCM) and dimethyldichlorosilane (DMDCS) were 159 
purchased from Fisher Scientific (Loughborough, UK). Ammonium acetate and 160 
37 % (w/v) hydrochloric acid solution were sourced from Sigma-Aldrich 161 
(Gillingham, Dorset, UK). Ultra-pure water was obtained from a Millipore Milli-162 
Q water purification system with a specific resistance of 18.2 MΩ.cm (Millipore, 163 
Bedford, USA). All glassware including stock solution vials and evaporation 164 
tubes were silanised to reduce loss of analyte through adsorption to the glass 165 
surfaces. Each component was rinsed with a 50:50 (v/v) MeOH/H2O solution 166 
before triplicate rinses with DCM. A 10:90 (v/v) DMDCS/DCM solution was then 167 
used to rinse the container followed by triplicate rinses with each of DCM, 50:50 168 
MeOH:H2O solution and water. A total of 51 pharmaceuticals, illicit drugs and 169 
metabolite reference materials were purchased from Sigma Aldrich 170 
(Gillingham, UK) for analytical method development and assessment (See 171 
Table S1. Stock solutions (1,000 mg L-1) were prepared in MeOH and working 172 
standard solutions prepared weekly in ultrapure water or LC mobile phase A. 173 
All solutions were stored in silanised amber glass vials at 4 °C in dark 174 
conditions.  175 
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 176 
2.2 Sampling sites and procedures 177 
Wastewater influent (immediately after the fine screen) and treated effluent 178 
were taken as seven 24-hour composite samples from a major sewage 179 
treatment works in London (population equivalent = 3.5 million) from 11-17th 180 
March 2014 to identify pharmaceuticals and illicit drug residues potentially 181 
indicative of CSO events. A 12-hour diurnal occurrence study was conducted 182 
using 13 hourly grab samples (500 mL) taken on Tuesday 12th August 2014, at 183 
Gabriel’s Pier, London (51°30'31.0" N; 0°06'35.1" W) covering a period from 184 
07:00 to 19:00 and collected at ~0.5 m depths. A moderate temperature (16-23 185 
oC), mainly dry day (<1 mm rainfall) was chosen to reflect a normal daily river 186 
cycle and free from storm runoff or triggered CSOs. For inter-season 187 
occurrence of pharmaceutical and illicit drug CSO marker candidates, samples 188 
were taken from two sites, again at ~0.5 m depths each time: Site 1 was at 189 
Lambeth Bridge (51°29'42.4"N 0°07'27.8"W) and Site 2 was at Gabriel’s Pier 190 
(as above). Of 57 vents in total in London, six CSO vents lay in close proximity 191 
to Site 2 in both directions, spanning from Westminster Bridge to Blackfriars 192 
Bridge. For Site 1, a CSO vent lay within 50 m of the sampling site on the same 193 
bank. Following this, a high frequency sampling campaign was conducted by 194 
taking grab samples over a 6-week period at 09:00 on weekdays from Site 2 195 
from 3rd November-13th December 2014. All samples of wastewater and river 196 
water were collected in 500 mL Nalgene bottles, transported immediately to the 197 
laboratory (~30-60 min transit time), acidified to < pH 2 with HCl and frozen (-198 
20 °C) until analysis. Tide heights were also recorded at the river sampling site 199 
at each timepoint using the local tidal gauge pole. Daily rainfall data for the 200 
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sampling site was gathered from the published CEH-GEAR dataset by Tanguy 201 
et al. [49].  202 
 203 
2.3 Sample pre-treatment and solid phase extraction  204 
Before extraction, samples were thawed and filtered under vacuum using 205 
Whatman GF/F 0.7 µm glass microfiber filters. For matrix-matched standards, 206 
acidified 100 mL sample aliquots were spiked volumetrically before solid phase 207 
extraction (SPE). HyperSep Retain Polar Enhanced Polymer (PEP) cartridges 208 
(200 mg x 6 mL) were selected for SPE of river water and wastewater (Thermo 209 
Fisher Scientific, Runcorn, UK). Cartridges were conditioned with 4 mL MeOH 210 
and 4 mL ultrapure water. Acidified samples (100 mL) were loaded under 211 
vacuum at ~5 mL min-1 and washed thereafter with 4 mL 5:95 (v/v) MeOH:H2O. 212 
The sorbent was dried under vacuum prior to elution for ~10 min before elution 213 
with 4 mL MeOH. Eluted extracts were evaporated to dryness under N2 at 35 °C 214 
and reconstituted in 100 µL of 10 mM ammonium acetate 90:10 215 
water:acetonitrile (mobile phase A) using a positive displacement pipette. The 216 
reconstituted samples were then sonicated for ~10 min before being transferred 217 
to an amber HPLC vial fitted with a silanised insert for analysis.  218 
 219 
2.4  Instrumentation 220 
For LC-HRMS analysis, an Accela ultra-high performance LC system, an HTS-221 
A5 autosampler (at 10 oC) and an ExactiveTM (Orbitrap) HRMS detector were 222 
used throughout. All separations were performed on a Thermo 150 × 2.1 mm, 223 
2.6 µm Accucore C18 analytical column fitted with a matching 10 × 2.1 mm, 2.6 224 
µm Accucore C18 guard column. The LC flow rate was 0.4 mL min-1, the 225 
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temperature was maintained at 24 oC and the injection volume was 20 µL. A 226 
binary gradient elution profile of 90:10 to 20:80 10 mM ammonium acetate in 227 
water:acetonitrile (mobile phase A and B, respectively) was used as follows: 228 
0% B for 2.5 min; 0-30% B from 2.5 to 7.5 min; 30% B from 7.5 to 12.5 min; 30-229 
40% B from 12.5 to 15 min; 40-100% B from 15.0 to 20.0 min; 100% B from 230 
20.0 to 27.5 min. Re-equilibration time was 7.5 min. The ExactiveTM HRMS was 231 
fitted with a heated electrospray ionisation source (HESI-II). All samples and 232 
model solutions were run separately in either positive or negative ionisation 233 
mode at 50,000 FWHM with a scan range of m/z 100–1000. Each acquisition 234 
cycle comprised of a full-scan without higher energy collisional dissociation 235 
(HCD) followed by a full scan with HCD enabled (collision energy: 20 eV; cycle 236 
time: ~2 s). Sheath, auxiliary and sweep gas settings were 50, 10 and 0 237 
arbitrary units, respectively. The capillary temperature was 350 oC; the heater 238 
temperature was 300 oC; and the positive/negative spray voltages were +4.50 239 
kV and −3.00 kV. All acquisition data was processed using Xcalibur v2.0 240 
software. The entire analytical method was validated to ICH guidelines in 241 
wastewater and river water (see Tables S2-S4) [50]. Method development 242 
details are also presented in the Supplementary Information. For wastewater 243 
influent and effluent, the method was found to be quantitative for n=33 and n=38 244 
compounds in untreated influent and treated effluent, respectively. For river 245 
water, the method could reliably quantify n=31 compounds at environmentally 246 
relevant concentrations. 247 
 248 
2.5 Targeted analysis,quantitation and statistical procedures 249 
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Confirmation of target analyte occurrence in all samples was based on the 250 
accurate mass of the protonated/deprotonated precursor ion and its associated 251 
major HCD product ion to within 5 ppm mass accuracy, the ratio between these 252 
two ions (<30 % to a matrix-matched standard) and a matching 253 
chromatographic retention time (tR) to within 15 s. For 24-h composite 254 
influent/effluent wastewater samples, duplicate aliquots were extracted for each 255 
day and determined using matrix-matched calibration using a pooled matrix of 256 
all samples across the week-long sampling period. Background correction was 257 
performed, as needed. Calibration lines were prepared for N ≥5 points, 258 
alongside triplicate background-corrected quality control samples (50 ng/L) to 259 
allow the accuracy of the method to be monitored. Given that the river was tidal 260 
and brackish, significant variance in analyte matrix effects across days was 261 
observed for a number of compounds (data not shown), so all drugs were 262 
determined in duplicate using 3-point standard addition in each sample 263 
separately for added accuracy. Drug occurrence in all samples is reported as 264 
the average of duplicates with error bars representing the larger of the two 265 
measurements. For temporal occurrence experiments, measured values over 266 
each timeframe were averaged and the associated variance expressed as the 267 
standard deviation, unless otherwise specified. 268 
All statistical treatment of data was performed in Microsoft Excel. For 269 
quantitation/calibration, lines-of-best-fit were applied and coefficients of 270 
determination (R2) calculated. For correlations between tide height/rainfall and 271 
drug concentration (Figure S4), the Pearson correlation (R) was calculated and 272 
significance tested by considering a p-value threshold of 0.05 to reject the null 273 
hypothesis. For statistical comparisons of drug removal efficiency from 274 
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wastewater, data was first checked for normality and the p-value quoted 275 
following application of the specified test. 276 
 277 
2.6 Suspect screening of wastewater and river water 278 
Suspect screening was performed on wastewater samples only to differentially 279 
identify unique drugs/metabolites or those with potentially higher 280 
concentrations in influent. Post-acquisition automated peak selection was 281 
performed using Thermo TraceFinderTM version 3.1 software which contained 282 
a library of HRMS spectra for n=1,492 pesticides, herbicides, fungicides, 283 
pharmaceuticals, metabolites and illicit drugs. Following this, predicted tR for 284 
potentially new compounds was performed using a previously developed neural 285 
network algorithm (Trajan v6.0, Trajan Software Ltd., Lincolnshire, UK) using 286 
reference tR data for 166 pharmaceuticals, illicit drugs and metabolites 287 
measured in influent and effluent wastewater extracts [51]. Compounds were 288 
tentatively identified using a tR window of ±1.3 min and an accurate m/z within 289 
5 ppm of its calculated m/z. Lastly, an 80% fit threshold to theoretical isotope 290 
profile was set, with an acceptable intensity threshold deviation for each isotope 291 
ion set at 25% of the theoretical value. 292 
 293 
2.7 DO, ammonium and conductivity monitoring 294 
Percentage DO, pH, conductivity (as a measure of salinity), and ammonium 295 
concentration were taken at 15-minute intervals by the Environment Agency 296 
(EA), UK and analysed at three sites (Putney, Brentford and Hammersmith) 297 
using YSI6600 systems (Environmental Monitoring Systems, Herts, UK). DO 298 
was measured as % saturation using the YSI optical DO Sensor. The Sonde 299 
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software automatically compensated for the effect of temperature. River pH was 300 
measured using a combination electrode with an Ag/AgCl reference electrode. 301 
Ammonium was measured using an YSI ion selective electrode and the 302 
reference being provided by the pH combination electrode. Conductivity (μS 303 
cm-1) was reported as specific to 25 oC and was calibrated using a solution of 304 
KCl. The YSI6600 sensors were calibrated every 4 weeks following standard 305 
EA operating procedures. 306 
 307 
3. Results and Discussion 308 
3.1 Differential analysis of influent and effluent wastewaters and 309 
identification of candidate CSO markers  310 
To shortlist a selection of CSO-related pharmaceutical and illicit drug markers, 311 
differential analysis of influent and effluent wastewaters was performed. Direct 312 
analysis of in-sewer CSO samples was not performed due to limited access. 313 
Two important criteria were considered. Candidate CSO drug markers were 314 
shortlisted where they were: (a) ideally only present in untreated influent 315 
wastewater (i.e. high removal efficiency in the WWTP); and (b) remained at 316 
measurable and relatively consistent concentrations every day (i.e., minimal 317 
seasonal variation or recreational usage patterns should be evident).  318 
All determined drug concentrations are presented in Tables S5 and S6 319 
and summarised in Figure 1. A total of 14 compounds were quantifiable almost 320 
every day in untreated influent wastewaters and two of these were unique to it, 321 
i.e. diazepam and sulfapyridine, present at 76 ±14 and 184 ±96 ng L-1, 322 
respectively, which were both selected as candidates. Prescription drug 323 
concentrations were generally consistent across the week in both influent and 324 
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effluent (except for sulfapyridine, which was not detected on one day). Both 325 
bezafibrate and furosemide were quantifiable in influent at similar 326 
concentrations (~400 ng L-1), but less than the lower limit of quantification 327 
(LLOQ) in effluent. This corresponded to an >10-fold lower concentration, so 328 
both were considered as potential CSO markers. Tramadol exhibited the 329 
opposite trend, with significantly higher levels detected in effluent at 1,138 ±106 330 
ng L-1 (p =3x10-7, Student’s two-tailed t-test), with over a two-fold concentration 331 
increase observed between both matrices. Nine other compounds were present 332 
at quantifiable levels on a regular basis in effluent. Extensive wastewater 333 
monitoring over the past five years as part of the £130 m UK Water Industry 334 
Research (UKWIR) Chemical Investigation Programme (CIP) Phase 2 (CIP2) 335 
has played a key role in the selection of substances and sites for future controls 336 
and remedial measures [52, 53]. It included up to 73 individual determinands 337 
across 44 WWTPs from 2015-2017 including data for six pharmaceutically-338 
related compounds for which removal rates could be calculated: diclofenac (42 339 
±29 %), ibuprofen (98 ±4 %), propranolol (28 ±24 %), carbamazepine (-8 340 
±35 %), carbamazepine epoxide (30 ±28 %) and fluoxetine (43 ±22 %) [54]. 341 
The London-based WWTP studied here was not included within the 44 CIP2 342 
sites. Comparative removal rates for this WWTP could be calculated reliably 343 
here for carbamazepine (-61 %, i.e., more concentrated in the effluent) and 344 
propranolol (34 %), and an estimation made for fluoxetine (65 %; occurrence 345 
was <LLOQ, but >LOD in influent).  346 
For the selected illicit drugs, most were quantifiable during the week 347 
except for methylenedioxymethamphetamine (MDMA) and generally increased 348 
over the weekend. This was consistent with recreational consumption trends 349 
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seen previously [15]. Ketamine was eliminated as a candidate CSO marker, as 350 
it was present at slightly higher concentrations in effluents than influents (58 ±5 351 
and 42 ±9 ng L-1, respectively)  and measurements also lay close to the LLOQ. 352 
Ketamine has been shown to display partial transformation in sewer transit 353 
(<25 %) [55], as well as variable and even negative removal rates following 354 
wastewater treatment [56, 57]. Possible reasons for higher concentrations in 355 
effluent include residence times below 24 h, as well cleavage of conjugated 356 
metabolites and desorption from particulate matter during treatment [58-60]. 357 
Mephedrone was detected at low levels in all samples and quantifiable at 83 358 
±45 ng L-1 in six out of seven influent samples (<LLOQ in effluent). Interestingly, 359 
concentrations of cocaine and its metabolite benzoylecgonine remained high in 360 
influent wastewater across the week with only a relatively minor increase in 361 
occurrence over the weekend (%RSD <10 % for benzoylecgonine and <25 % 362 
for cocaine), which is not consistent with many other cities. London is known as 363 
one of the highest consumers of cocaine and this result suggested everyday 364 
usage [16]. Cocaine was detected at significantly higher levels in influent (p 365 
=3x10-5; Student’s two-tailed t-test) as well as analyte concentrations in effluent 366 
at ~30-fold lower levels, which represented >99 % removal efficiency at this 367 
WWTP. While WWTP removal performances can differ between sites, similar 368 
removal of cocaine and benzoylecgonine from influent has been reported in 369 
other parts of UK and globally, even up to 100 % [57, 61]. Given their metabolic 370 
linkage, both were given further consideration as CSO markers. In addition to 371 
these compounds, caffeine was also detected only in influent. However, its 372 
concentration was so high that it lay outside of the quantifiable range when 373 
using background corrected matrix-matched standard addition. However, 374 
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previous work using stable isotope internal standards showed that caffeine 375 
concentration in untreated wastewater from London was quite stable at 23 ±2 376 
µg L-1 across a full week [15]. Caffeine has also been shown to be removed 377 
almost completely by wastewater treatment processes by both aerobic and 378 
anaerobic degradation [57, 62]. Caffeine was therefore retained as a candidate 379 
CSO marker and more reliable measurements in river water matrix were 380 
possible when present at a diluted concentration. Another compound, salicylic 381 
acid, was present at excessively high concentrations to quantify it in influent 382 
and was not detected in effluent. However, the poor method performance for 383 
this compound, observed in all three matrices assessed, meant it was not 384 
suitable for quantitative monitoring and was eliminated for use.   385 
Application of HRMS database searching (TraceFinder) and reference 386 
to matching predicted chromatographic retention times resulted in tentative 387 
identification of n=32 more drug residues in influent and n=28 more in effluent 388 
across the week (Tables S7 and S8). For influent only, two detectable 389 
chromatographic peaks were present for four compounds in extracted ion 390 
chromatograms within their 1.3 min retention window even at 5 ppm mass 391 
accuracy/isotope profile matching (i.e., matching hydrocortisone, salbutamol, 392 
testolactone and acetylsalicylic acid, but not confirmed with reference 393 
standards). A total of 14 compounds were detected in influent at higher signal 394 
intensities than effluent at least once across the week (Figure 2 and Table S9). 395 
Eleven compounds were tentatively identified in effluent every day, including 396 
nine also present in influent every day. However, two unresolved isomers 397 
(quinine and quinidine) were present at markedly higher signal intensities in 398 
influent and were used together as a combined signal as potential CSO 399 
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markers. It was expected that of the two, quinine was likely to be the dominant 400 
compound given its widespread use in tonic waters.  401 
A total of seven target analytes (bezafibrate, benzoylecgonine, caffeine, 402 
diazepam, sulfapyridine, cocaine and furosemide) were shortlisted as 403 
candidate CSO markers quantitatively. Quinine and quinidine were used 404 
together as qualitative CSO markers. For the six-week monitoring study, all 405 
other compounds were still included for river water monitoring, even if not 406 
considered as potential CSO markers to assess the potential contribution of 407 
CSOs in general.  408 
 409 
3.2 Diurnal variation in drug concentrations in the River Thames 410 
The river sampling sites in Central London lay within the Thames Estuary, 411 
where river levels often change by up to seven metres, twice a day. River flow 412 
is relatively small compared with the volume of the tide and therefore, is well 413 
mixed. Generally, the entire water mass travels in and out of the estuary with 414 
tidal cycles. When CSOs discharge to the river, it takes approximately one 415 
month for litter and sewage to exit the estuary to the sea in Winter and up to 416 
three months in Summer [24]. River water is also brackish to the top of the 417 
estuary at Teddington Lock, which lies west of the city. Previous research has 418 
shown that varying salinity, dissolved organic carbon (DOC) and/or suspended 419 
particulate matter (SPM) can influence drug concentrations in tidal waters [42, 420 
43]. Therefore, fluctuations in drug concentration were monitored over a tidal 421 
cycle on a day free from storm water runoff or CSOs to understand the impact 422 
of fresh/saline water changes. From a qualitative perspective, n=24/31 423 
compounds included in the validated method were detected at least once 424 
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across the day at Site 2 (Table S10) showing that the selection of compounds 425 
was highly relevant to this catchment and benefited greatly from the use of 426 
flexible full-scan LC-HRMS-based methods. Of these, n=18 drug residues were 427 
quantifiable and n=13 of those determined at all sampled time points. Figure 428 
3(a) shows that four potential CSO marker drugs were quantifiable and 429 
remained relatively low in concentration. As perhaps expected, caffeine was 430 
present at the highest concentration across the day at 112 ±48 ng L-1, and it 431 
presented a minor correlation with tide. No obviously apparent correlation with 432 
tide was observed for the other three CSO markers and all remained below ~20 433 
ng L-1. Figure 3 (b)-(d) show the other determined pharmaceutical residues, 434 
again most of which showed low and relatively consistent concentration 435 
profiles. Tramadol and carbamazepine concentrations were the highest 436 
between ~100-300 ng L-1 over the 12-hour period. Tramadol occurrence has 437 
been linked to hospital effluent contribution to CSOs, but was present at lower 438 
concentrations in untreated wastewaters here [63]. Trimethoprim, 439 
sulfamethazine, carbamazepine and ketamine were the only obvious cases 440 
showing any correlation with tide or water conductivity. These almost doubled 441 
in concentration at high tide which was in contrast to observations for 442 
pharmaceuticals by some other researchers [42, 43]. Three of London’s five 443 
WWTPs (Beckton, Riverside and Crossness) discharge treated wastewater into 444 
the Thames ~25-30 km to the east of the Central London location (Site 2) and 445 
serve a combined population equivalent of ~5.9 million (~71 % of Greater 446 
London). The remainder of the population is served mainly by Mogden WWTP, 447 
which discharges effluent ~25 km west of Site 2 (~2 million population 448 
equivalent). Therefore, concentration rises with high tide are likely due to drug 449 
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residues from more treated effluent entering downstream being swept inland 450 
towards Site 2. Therefore, and in general, drug residues were not removed from 451 
the sampling site by a tidal cycle and concentrations largely remained relatively 452 
consistent. This was particularly useful for CSO markers considering that river 453 
water conductivity changed from ~650-1,000 µS cm-1 across the tidal cycle on 454 
this date showing the salt water influx/efflux. 455 
 456 
3.3 Inter-season occurrence of pharmaceutical and illicit drug CSO marker 457 
candidates 458 
CSOs were categorised into two main types. CSO Type 1 comprised of storm 459 
water combined with untreated sewage, which was discharged directly into the 460 
river. CSO Type 2 represented heavily diluted storm water that was screened, 461 
settled in tanks and mixed with fully treated wastewater at a major WWTP 462 
before release to the river. Public notifications of either CSO type corresponded 463 
to two monitored sites in London: (a) Hammersmith pumping station (CSO Type 464 
1) and (b) Mogden WWTP (CSO Type 2). Weather in January 2014 was one of 465 
the wettest on record since 1910 with ~135 mm rainfall and available data from 466 
Hammersmith Pumping Station alone revealed ~1,637,456 m3 of CSO Type 1 467 
discharge and 2,505,000 m3 of Type 2 from Mogden WWTP [64]. However, the 468 
total volume of either CSO type was likely much higher given that several more 469 
pumping stations and CSO vents exist across the Central London catchment. 470 
Across 2014, 16 million tonnes of untreated sewage were discharged into the 471 
River Thames from just the central London CSO vents covering the two 472 
sampling points selected. Three of these (the Hammersmith, Lots Road, and 473 
Western Pumping Stations) contributed 11 million tonnes to that total. One Type 474 
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1 CSO event occurred during the week sampled in winter on 16th January, 2014 475 
at 21:50 hours, but after a grab sample was taken. However, concentrations of 476 
caffeine and benzoylecgonine increased at both Sites 1 and 2 on the following 477 
day (Figure 4). Furthermore, at Site 1 increases in concentration were also 478 
observed for bezafibrate and cocaine, most likely as it lay so close to a CSO 479 
vent, but this trend was not observed at Site 2. Caffeine had the highest 480 
concentration overall and reached a maximum of 1,520 ng L-1 at Site 1 and 481 
~13 h after this Type 1 CSO. Its high concentration was prolonged in this 482 
instance and took roughly two days to return to baseline concentrations. No 483 
CSOs occurred during the week of sampling in July, 2014. Only ~44 mm rainfall 484 
was recorded for the month with 24,000 m3 of Type 1 CSO discharge from 485 
Hammersmith Pumping Station and no Type 2 CSO discharge from Mogden 486 
WWTP. By comparison, caffeine concentrations were much lower in Summer 487 
and rarely reached >200 ng L-1. Detection of all other substances was 488 
intermittent. Interestingly, baseline concentrations of bezafibrate and 489 
benzoylecgonine remained relatively consistent with the January samples, 490 
despite recorded rainfall and tidal height differences of >3.5 m across all 491 
sampling timepoints.  At this time of year, salinity of the river was also much 492 
higher and more affected by tide as its freshwater composition was much lower 493 
(conductivity of ~600-700 µS in the Winter dates studied versus 900-3,000 µS 494 
in Summer) 495 
 496 
3.4 Longitudinal daily monitoring of pharmaceutical and illicit drug 497 
occurrence in the River Thames over six weeks 498 
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Site 2 was selected for a longitudinal occurrence study of all 31 499 
pharmaceuticals given its convenience, reliability and safety of access during 500 
bad weather across six weeks in Autumn and Winter, 2014. Furthermore, it 501 
represented an equidistant point in the river between the major west and east 502 
WWTP discharge points (~25 km in either direction). A total of 27 drug residues 503 
were determined in the River Thames (Figure 5). The total (summed) 504 
concentration of all compounds monitored varied from ~1-3.5 µg L-1.  505 
Over the course of the study, 13 CSOs were triggered due to heavy 506 
rainfall (Table S11). In all, six Type 1 CSOs were recorded over the six-week 507 
period, which were most relevant to this study. Of these, four samples were 508 
taken within 24 hours following a CSO event. Available Type 1 CSO-related 509 
records from the Hammersmith, Lotts Road and Western pumping stations 510 
showed that a combined total of 1,883,485 and 204,150 m3 of untreated 511 
sewage mixed with storm water was discharged into the Central London region 512 
of the River Thames in November and December months, respectively [64]. 513 
Measured total concentrations of illicit drugs and pharmaceuticals decreased in 514 
general throughout November and December (Figure 5 and Table S12). 515 
Approximately 75 % (~80-90 mm) of the total rainfall fell in the first three weeks. 516 
Dilution with freshwater arising from the upper Thames may have been a 517 
contributor to this decline, amongst other factors such as changing temporal 518 
consumption patterns, varying WWTP performance, changing river water 519 
chemistry (e.g., salinity, etc.), molecular stability and biological activity. On the 520 
other hand, prolonged elevated concentrations following CSOs could have 521 
arisen here where several events occurred in rapid succession, especially in 522 
the first three weeks, and which were slowly removed by the tide. The top five 523 
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most concentrated compounds on average across the six weeks were caffeine 524 
(477 ±313 ng L-1), diazepam (305 ±558 ng L-1), tramadol (220 ±75 ng L-1), 525 
carbamazepine (154 ±99 ngL-1) and amitriptyline (102 ±57 ngL-1). Temporal 526 
variance in measured concentrations across the 30 sampled days was, as 527 
perhaps expected, high and not likely to only include any impact of CSOs, but 528 
also changes in community consumption behaviour, illness/disease treatments 529 
or seasonal consumption patterns influencing the concentrations in treated 530 
wastewater effluents [65]. Where Type 1 CSOs occurred, no readily identifiable 531 
spikes in total concentration of all drugs determined were observed within a 24 532 
to 48hour period, nor any correlations with tide height, daily rainfall, or a ratio 533 
of both (R2 <0.1 in all cases). Principal component analysis did not yield any 534 
further classification between daily concentrations determined for all 27 535 
compounds (Figure S2). In addition, five out of six Type 1 CSOs were also 536 
accompanied by Type 2 CSOs, which may have served to dilute untreated 537 
wastewater entering the Thames Tideway further. Some additional interesting 538 
observations were made. The illicit drugs ketamine and mephedrone were 539 
detected almost every day at 12 ±4 ngL-1 and 9 ±2 ng L-1, respectively. The 540 
latter was banned in the UK in 2010, but was still determined in wastewater 541 
influent, effluent and river water here in 2014. However, despite being present 542 
at higher concentrations in influent, its concentration flux did not align with 543 
CSOs, likely in part due to recreational use increasing over the weekend. 544 
When focussing on the seven shortlisted candidate CSO markers, some 545 
trends became more evident, but were very complex to interpret. Firstly, 546 
concentrations of caffeine, cocaine and its metabolite benzoylecgonine in river 547 
water showed a correlation with some CSOs. As their concentrations in 548 
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untreated wastewater was regularly >1 µg L-1, this was perhaps expected over 549 
the other four compounds. Elevated concentrations were mainly detected in 550 
samples taken on the following day (Figure 6) especially following the two 551 
heaviest rainfall events and CSOs on 23rd November and 11th December, 2014, 552 
both during the lower portion of incoming flood tidal phases. For the latter date, 553 
two CSOs were triggered on the following day at 06:25 (Type 1) and 08:58 554 
(Type 2) just before the sample was taken and which enabled subsequent 555 
determination of all compounds at higher concentrations, even within 3 hours 556 
following a Type 1 discharge. However, neither cocaine nor benzoylecgonine 557 
were detected at obviously elevated levels following Type 1 CSOs on the 4th or 558 
14th November. On both occasions, the river was at the top of its tidal phase 559 
and dilution may have occurred. As before, elevated caffeine concentration 560 
following CSOs seemed prolonged over several days in comparison to cocaine, 561 
especially after the heaviest rain event on the 22nd/23rd November. 562 
Concentrations of diazepam were high across the first two weeks of the 563 
campaign and then decreased markedly thereafter and did not correlate with 564 
any one CSO event directly. Short-term elevated concentrations may be more 565 
prolonged for this compound given its potential for sorption to sediment [66]. 566 
Following the CSO event on the 4th November, elevated concentrations of 567 
sulfamethazine and sulfamethoxazole occurred, and a mild rise in 568 
concentration of sulfapyridine over the following 48 h. However, sulfapyridine 569 
was not useful to indicate other Type 1 CSO events across the remainder of 570 
the campaign. Lastly, furosemide and bezafibrate yielded no apparent trends 571 
and were removed from further interpretations.  572 
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The majority of compounds tentatively identified during suspect 573 
screening as being indicative of influent wastewater were not present in river 574 
water. However, the combined signal for the stereoisomers quinine/quinidine 575 
was detected every day ([M+H]+ m/z 325.1910), but revealed no obvious co-576 
incidence with CSO events (Figure S3). However, achieving chromatographic 577 
resolution of both compounds and quantification is still required to fully evaluate 578 
their individual value as CSO markers. Furthermore, the use of signal intensities 579 
from LC-HRMS analysis was likely subject to variable matrix interference due 580 
to the influence of seawater with tide, especially over the first week of the 581 
sampling campaign (Figure 7(a)). However, for the majority of the six seeks, 582 
conductivity measurements indicated that the river was predominantly 583 
composed of freshwater (600-800 µS), mainly arising from influx of upstream 584 
sources to Teddington Lock experiencing heavy rainfall and run-off. 585 
 586 
3.5 Ammonium, pH and %DO 587 
Comparison of drug concentrations with ammonium and %DO data 588 
gathered simultaneously from Putney, Hammersmith and Brentford (each 589 
~5-7 km apart) in the west of the city revealed correlations with most Type 1 590 
CSOs (Figure 7 (b)-(d)). Interestingly, and despite their distances apart, the 591 
changes in ammonium/%DO concentrations at each site aligned well with each 592 
other, indicating that CSOs may be triggered across the length of the network 593 
simultaneously. However, and in agreement with some of the drug 594 
measurements here, poorly discernable changes in ammonium concentration 595 
or %DO were observed for Type 1 CSOs on the 4th, 8th or 9th November (only 596 
observed clearly at the Brentford site). The pH of the river remained relatively 597 
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constant over the six weeks (pH = 7.77 ±0.09), and very minor reductions of 598 
<0.25 pH units were observed during periods of elevated ammonium 599 
concentration. 600 
The duration of CSO impacts could be interpreted from ammonium 601 
and %DO data (unfortunately, data for CSO duration and discharge volumes 602 
were not available for specific dates). Generally, and like CSO drug markers, 603 
changes occurred within 24 h after a CSO and returned to normal levels ~24 h 604 
later. A mild positive, but statistically significant correlation (R =0.6023; 605 
p=0.0049) existed between total concentrations of the three main CSO drug 606 
markers determined on the following day with tide height:daily rainfall ratio at 607 
the time of sampling (Figure S4). Therefore, it was concluded that there exists 608 
a fine balance between tide height/direction, rainfall and time (<24 h here) 609 
before an influent wastewater-specific drug can be measured in the river to 610 
potentially indicate CSO influx. The Type 1 CSO event on the 23rd of November 611 
2014 was the most prominent and prolonged from these data which explains 612 
why concentrations of some CSO drug markers increased so markedly. The 613 
Putney site is closest by distance to Site 2 chosen for drug monitoring (~11 km). 614 
Despite being more central, smaller changes in ammonium and %DO were 615 
observed across the six-week period. Therefore, proximity to a local CSO vent 616 
will likely affect measurements overall. Ideally, more sites should be monitored 617 
across this catchment to more fully understand spatial impacts of 618 
pharmaceuticals and illicit drugs from CSOs on receiving waters. However, 619 
despite short-lived peaks in concentration, longer term concentrations of 620 
pharmaceuticals and illicit drugs in CSO material may decline overall upon 621 
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completion of the Thames Tunnel, which aims to reduce annual sewage 622 
discharge via CSOs by 95 % [27]. 623 
 624 
Conclusions 625 
Of 31 compounds monitored quantitatively, 27 pharmaceuticals and illicit drug 626 
residues were determined in river water in the Thames Tideway in daily 627 
measurements over six weeks. However, occurrence and total concentrations 628 
of pharmaceuticals and illicit drugs as a whole showed no short-term correlation 629 
with specific CSO events (total concentration lay between ~1.0-3.5 µg L-1). 630 
Following differential analysis of influent and effluent wastewater, seven 631 
compounds were shortlisted as potentially being influent wastewater specific 632 
and three of these were present at concentrations >1,000 ng L-1 in influent (i.e. 633 
caffeine, cocaine and benzoylecgonine). In river water, these three compounds 634 
showed noticeably elevated concentrations ~24-48 h after CSO events 635 
following major rainfall events and aligned with ammonium and %DO data. It 636 
was found that there existed a fine balance between tide height, direction and 637 
rainfall, before any elevated concentrations of these CSO markers were 638 
recorded. Therefore, CSO releases should be ideally aligned with the onset of 639 
the ebb tidal phase to enable sufficient dilution to occur. However, even with 640 
dilution, more research is required to understand the longer-term impacts of 641 
CSOs on drug occurrence in receiving waters and particularly any potential 642 
improvements following a major infrastructure upgrade such as that planned in 643 
London to mitigate them. 644 
 645 
 646 
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 904 
 905 
Figure 1. Differential analysis of drug occurrence in untreated influent and 906 
treated effluent wastewaters from a major treatment works in London in n=7 907 
consecutive 24-h composite samples in March, 2014. Bars marked with * 908 
represent semi-quantitative measurements as values were <LLOQ, but >LOD. 909 
Error bars represent the standard deviation of the means of all measurements 910 
for each compound across the 7-day period. 911 
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 914 
 915 
Figure 2. Average signal intensity for each compound tentatively identified by 916 
retrospective in silico suspect screening in (a) untreated influent and (b) 917 
treated effluent wastewaters. Their corresponding occurrence frequency out of 918 
7 days is shown in parenthesis. Bars represent the mean and whiskers 919 
represent the standard deviation of that number of daily measurements in (c) 920 
and (d). Compounds marked with * represent those where two matching 921 
predicted tR values (±1.30 min threshold) and HRMS signals (δ <5ppm for 922 
[M+H]+ or [M-H]-) were obtained.  923 
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 925 
Figure 3. Diurnal variation in (a) CSO marker drug compounds and (b)-(d) all other drug compounds determined above the LLOQ 926 
in the River Thames on the 14th August, 2014. Black datapoints represent the mean of n=2 replicate grab sample analyses. Grey 927 
dashed lines represent the measured tide height at the time of sampling. No CSOs occurred on this day (<1 mm rainfall). 928 
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 929 
 930 
Figure 4.  Measured concentrations of seven shortlisted candidate drug CSO 931 
markers in samples of Thames River water from two sites in January and July 932 
2014 and overlaid with daily rainfall. A Type 1 CSO occurred on on 17th 933 
January, 2014 at 21:50 hours (shaded in grey).  Note: No sample was taken 934 
from Site 1 on 21st July, 2014.  All measurements represent the mean of n=2 935 
replicates.936 
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 937 
 938 
Figure 5. Cumulative concentration of all drug residues determined on 939 
weekdays in the River Thames across Nov-Dec, 2014. Dates marked with + 940 
are Type 1 CSOs where storm water and untreated sewage were combined 941 
and released directly into the river. Dates marked with  represent Type 2 CSO 942 
events where storm water was mixed with treated wastewater effluent at a 943 
WWTP and then released into the river (where both + and  exist, two such 944 
CSOs occurred on the same date, also see Table S11).  945 
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 947 
Figure 6. Occurrence of three drug CSO markers in river water from the 948 
Thames over six weeks in Nov-Dec, 2014 (overlaid with daily rainfall). Dates 949 
marked with + or  are as in Figure 5. Bars represent the mean of two replicates 950 
and whiskers represent the maximum value measured. 951 
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 953 
Figure 7. Continuous monitoring data at three sites on the River Thames in 954 
Nov-Dec, 2014 for (a) conductivity and (b)-(d) % DO (red)/ammonium 955 
concentration (black) at Hammersmith, Brentford and Putney sites, 956 
respectively. Data-acquisition frequency =15 min. Dates marked with / 957 
represent CSO Types 1 and/or 2, respectively. 958 
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